What does Santen Pharmaceutical invest in?
Santen Pharmaceutical invests most often at Series B and Series A (75% of the rounds on record), in sectors such as Cloud Security, Software and Biotechnology.
United States · Investor
Last cheque observed Nov 2015. Silence since then is not evidence of inactivity: our sources miss unannounced rounds.
QuietCorporate VC
4 rounds on record
Mostly Series B and Series A: 75% of its rounds
Every round we can evidence, newest first4 appearances
2 rounds
2 rounds
An announcement gives the size of the round, not the size of this investor's cheque: the only rounds that imply a cheque are those where they were the sole named investor.
Santen Pharmaceutical invests most often at Series B and Series A (75% of the rounds on record), in sectors such as Cloud Security, Software and Biotechnology.
4 investments on record, 0 of them in the last 12 months. The most recent was in Nov 2015.
The median round it joins is $11M.
No investments in the last 12 months; the latest was in Nov 2015.
Santen Pharmaceutical is a corporate VC based in Osaka, United States.
Santen Pharmaceutical was founded in 1993.
From public registers and its own website, checked and rebuilt every night.
Find the investors who back rounds like yours, and keep every conversation on one fundraising board.
Built from the rounds we watched, its filings and its own website, refreshed every night. How we count · Report a correction · Is this your firm? Claim it